MIDATECH PHARMA
Partnerships | In Licensing
                                     

Commercial Partnerships

Midatech has comprehensive commercial coverage across the US oncology market through a series of agreements with a number of specialty pharmacy providers, leading group purchasing organisations (GPOs), retail partners, reimbursement experts, and an industry-leading third-party logistics provider. As part of an integrated national network with annual sales of over $1 billion in cancer therapeutics, Midatech has significant commercial scale and capabilities. Its distribution network consists of more than 45,000 retail pharmacies, mail order pharmacies, and long-term care facilities. This provides Midatech with established reimbursement and logistics expertise, as well as partnering opportunities with sales and marketing personnel uniquely focused on oncology and oncology support products. This comprehensive network of partners is rare if not unique among companies in the oncology supportive care area and provides Midatech a strong foundation for product introductions into the oncology market.

Business Development

Our business development efforts are focused on actively identifying in-licensing opportunities to expand our oncology supportive care focus product portfolio. Areas of interest include both oncology supportive care products as well as oncology therapeutics.
If you are interested in exploring business development opportunities with Midatech Pharma US, please contact:

Rob Rainey
Head of Corporate Development

E: rob.rainey@midatechpharma.com

 

David Benharris
President

T: +1 919-861-0158
E: david.benharris@midatechpharmaus.com

Partnerships
In Licensing
                                     

Commercial Partnerships

Midatech has comprehensive commercial coverage across the US oncology market through a series of agreements with a number of specialty pharmacy providers, leading group purchasing organisations (GPOs), retail partners, reimbursement experts, and an industry-leading third-party logistics provider. As part of an integrated national network with annual sales of over $1 billion in cancer therapeutics, Midatech has significant commercial scale and capabilities. Its distribution network consists of more than 45,000 retail pharmacies, mail order pharmacies, and long-term care facilities. This provides Midatech with established reimbursement and logistics expertise, as well as partnering opportunities with sales and marketing personnel uniquely focused on oncology and oncology support products. This comprehensive network of partners is rare if not unique among companies in the oncology supportive care area and provides Midatech a strong foundation for product introductions into the oncology market.

Business Development

Our business development efforts are focused on actively identifying in-licensing opportunities to expand our oncology supportive care focus product portfolio. Areas of interest include both oncology supportive care products as well as oncology therapeutics.
If you are interested in exploring business development opportunities with Midatech Pharma US, please contact:

Rob Rainey
Head of Corporate Development

E: rob.rainey@midatechpharma.com

 

David Benharris
President

T: +1 919-861-0158
E: david.benharris@midatechpharmaus.com

© Copyright 2017 Midatech Pharma PLC